American Healthcare REIT Statistics
Total Valuation
AHR has a market cap or net worth of $7.30 billion. The enterprise value is $8.85 billion.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | Jun 30, 2025 |
Share Statistics
AHR has 170.58 million shares outstanding. The number of shares has increased by 64.92% in one year.
| Current Share Class | 168.58M |
| Shares Outstanding | 170.58M |
| Shares Change (YoY) | +64.92% |
| Shares Change (QoQ) | +2.69% |
| Owned by Insiders (%) | 0.88% |
| Owned by Institutions (%) | 88.88% |
| Float | 167.10M |
Valuation Ratios
| Price/FFO Ratio | 30.20 |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | 68.28 |
| PS Ratio | 3.02 |
| Forward PS | 3.16 |
| PB Ratio | 2.90 |
| P/TBV Ratio | 3.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 28.54 |
| PEG Ratio | 5.86 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.13 |
| EV / EBITDA | 24.49 |
| EV / EBIT | 57.19 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.70.
| Current Ratio | 1.61 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 4.30 |
| Debt / FCF | n/a |
| Interest Coverage | 1.46 |
Financial Efficiency
Return on equity (ROE) is -1.41% and return on invested capital (ROIC) is 2.27%.
| Return on Equity (ROE) | -1.41% |
| Return on Assets (ROA) | 2.11% |
| Return on Invested Capital (ROIC) | 2.27% |
| Return on Capital Employed (ROCE) | 3.69% |
| Revenue Per Employee | $18.79M |
| Profits Per Employee | -$287,675 |
| Employee Count | 114 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 89.24 |
Taxes
In the past 12 months, AHR has paid $2.09 million in taxes.
| Income Tax | 2.09M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +103.86% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +103.86% |
| 50-Day Moving Average | 38.72 |
| 200-Day Moving Average | 32.28 |
| Relative Strength Index (RSI) | 81.16 |
| Average Volume (20 Days) | 1,607,468 |
Short Selling Information
The latest short interest is 3.84 million, so 2.25% of the outstanding shares have been sold short.
| Short Interest | 3.84M |
| Short Previous Month | 5.37M |
| Short % of Shares Out | 2.25% |
| Short % of Float | 2.30% |
| Short Ratio (days to cover) | 3.01 |
Income Statement
In the last 12 months, AHR had revenue of $2.14 billion and -$32.80 million in losses. Loss per share was -$0.22.
| Revenue | 2.14B |
| Gross Profit | 381.12M |
| Operating Income | 154.82M |
| Pretax Income | -34.19M |
| Net Income | -32.80M |
| EBITDA | 361.50M |
| EBIT | 154.82M |
| Loss Per Share | -$0.22 |
Full Income StatementBalance Sheet
The company has $134.02 million in cash and $1.72 billion in debt, giving a net cash position of -$1.58 billion or -$9.28 per share.
| Cash & Cash Equivalents | 134.02M |
| Total Debt | 1.72B |
| Net Cash | -1.58B |
| Net Cash Per Share | -$9.28 |
| Equity (Book Value) | 2.46B |
| Book Value Per Share | 14.71 |
| Working Capital | 188.88M |
Full Balance SheetCash Flow
| Operating Cash Flow | 254.73M |
| Capital Expenditures | -101.64M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 17.79%, with operating and profit margins of 7.23% and -1.53%.
| Gross Margin | 17.79% |
| Operating Margin | 7.23% |
| Pretax Margin | -1.41% |
| Profit Margin | -1.53% |
| EBITDA Margin | 16.88% |
| EBIT Margin | 7.23% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $1.00, which amounts to a dividend yield of 2.34%.
| Dividend Per Share | $1.00 |
| Dividend Yield | 2.34% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -64.92% |
| Shareholder Yield | -62.57% |
| Earnings Yield | -0.45% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for AHR is $41.89, which is -2.10% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.89 |
| Price Target Difference | -2.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
